Clinical Trial Update: PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal Care Pathway for TAVI

View source ↗

Summary

This clinical trial registry update describes the PERFECT registry evaluating the Evolut FX+ Transcatheter Aortic Valve System for an optimal care pathway in tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• Evolut FX+ TAVI System

Snippet

Sponsor: Portuguese Association of Interventional Cardiology | Conditions: Severe Symptomatic Aortic Stenosis (Defined as New York Heart Association (NYHA) Class ≥ II) | Status: RECRUITING